Friday, December 19, 2025

Agnico Eagle Mines Ltd

Sound bite for Twitter is: Dividend Paying Material. Results of stock price testing is that the stock price is probably expensive. Debt Ratios are good. The Dividend Payout Ratios (DPR) are currently good. The current dividend yield is low with dividend growth that has been good and has recently stalled. See my spreadsheet on Agnico Eagle Mines Ltd.

Is it a good company at a reasonable price? When dividend growth stalls it is never a good sign. Analysts seem to expect a big increase in EPS and AEPS in 2025, and yet the company had not raised the dividends? And there is insider selling.

I do not own this stock of Agnico Eagle Mines Ltd (TSX-AEM, NYSE-AEM). Recently, two mining stocks were recommended. Agnico-Eagle Mines Ltd (TSX-AEM) was recommended by Advice for Investors site. Franco-Nevada (FNV.T) was recommended by a member of Ellen’s Investment Club. I decided to look at Agnico-Eagle Mines because it was on the Money Sense List of Dividend Stocks.

When I was updating my spreadsheet, I noticed that growth has been quite good and shareholders have done well, but you have to be careful when you buy and not pay too much. This stock has cyclical in the past, but it has really taken off from 2023 and almost straight up. So far this year the stock price is up 107%.

All the officers I am following, including the CEO and CFO have sold shares in the last year. The Chairman has also sold shares. The other directors I am following bought some shares.

If you had invested in this company in December 2014, for $1,017.10 you would have bought 35 shares at $29.06 per share. In December 2024, after 10 years you would have received $431.39 in dividends. The stock would be worth $3,936.10. Your total return would have been $4,367.49. This would be a total return of 16.43% per year with 14.49% from capital gain and 1.94% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$29.06 $1,017.10 35 10 $431.39 $3,936.10 $4,367.49

The current dividend yield is low with dividend growth that has been good and has recently stalled. The current dividend yield is low (below 2%) at 0.91%. The 10 year and historical median dividend yields are also low at 1.35% and 1.05%. The 5 year median dividend yield is moderate (2% to 4%) at 2.49%. The dividend yield has gone down recently because this stock’s stock price has soared. The dividend growth for the past 5 years is good and up 23% per year. However, there has been no dividend increase since 2022.

The Dividend Payout Ratios (DPR) are currently good. The DPR for 2024 for Earnings per Share (EPS) is good at 42% with 5 year coverage high at 53%. The DPR for 2024 for Adjusted Earnings per Share (AEPS) is good at 38% with 5 year coverage high at 58%. The DPR for 2024 for Cash Flow per Share (CFPS) is good at 20% with 5 year coverage high at 24%. The DPR for 2024 for Free Cash Flow (FCF) is good at 39% with 5 year coverage at high at 59%. In 2024, FCF varies from $2,050M to $4,185M and I am using the $2,050M value. Expected DPR for 2025 is 19% because analysts expect a big increase in EPS.

Item Cur 5 Years
EPS 42.33% 52.65%
AEPS 37.83% 57.78%
CFPS 20.80% 24.16%
FCF 39.38% 59.34%

Debt Ratios are good. The Long Term Debt/Market Cap Ratio for 2024 is good at 0.15 and currently at 0.07. The Liquidity Ratio for 2024 is good at 1.86 and 1.75 currently. The Debt Ratio for 2024 is good at 3.94 and 3.20 currently. The Leverage and Debt/Equity Ratios for 2024 are good at 1.44 and 0.44 and currently at 1.45 and 0.45.

Type Year End Ratio Curr
Lg Term R 0.15 0.07
Intang/GW 0.10 0.05
Liquidity 1.86 1.75
Liq. + CF 3.94 5.05
Debt Ratio 3.28 3.20
Leverage 1.44 1.45
D/E Ratio 0.44 0.45

The Total Return per year is shown below for years of 5 to 21 to the end of 2024 in CDN$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2019 5 26.37% 8.66% 6.63% 2.03%
2014 10 20.02% 16.43% 14.49% 1.94%
2009 15 18.16% 5.83% 4.66% 1.17%
2004 20 23.09% 11.43% 10.06% 1.37%
2003 21 21.47% 11.12% 9.84% 1.29%

The Total Return per year is shown below for years of 5 to 21 to the end of 2024 in US$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2019 5 23.81% 6.76% 4.69% 2.07%
2014 10 17.46% 14.00% 12.11% 1.89%
2009 15 15.68% 3.71% 2.54% 1.18%
2004 20 22.00% 10.65% 9.14% 1.52%
2003 21 20.85% 10.78% 9.31% 1.47%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 19.32, 27.95, 34.35. The corresponding 10 year ratios are 20.78, 29.46 and 37.20. The corresponding historical ratios are 22.27, 29.46 and 37.20. The current ratio is 21.22 based on EPS estimate for 2025 of $11.40 and a stock price of $241.78. The current ratio is between the low and median ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median. This testing is in CDN$. You have to wonder why analysts think that the EPS will go up 119% this year from $3.78 to $8.28 US$.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are 19.46, 24.48 and 29.51. The corresponding 10 year ratios are 29.62, 39.11, and 48.71. The corresponding historical ratios are 25.27, 35.48, and 46.89. The current ratio is 21.96 based on AEPS estimate for 2025 of $7.99 and a stock price of $175.44. The current ratio is below the low of the 10 year median ratios. This stock price testing suggests that the stock price is cheap. This testing is in US$ and you will get a similar result in CDN$. Analysts expect the AEPS to go up 89% from 4.23 to $7.99.

I get a Graham Price of $117.69. The 10-year low, median, and high median Price/Graham Price Ratios are 1.50, 2.11 and 2.53. The current ratio is 2.05 based on a stock price of $241.78. The current ratio is between the low and median ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median. This testing is in CDN$.

I get a 10-year median Price/Book Value per Share Ratio of 2.13. The current P/B Ratio is 4.32 based on a Book Value of $20,505.M, Book Value per Share of $41.29 and a stock price of $175.44. The current P/B Ratio is 103% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. This testing is in US$ and you will get a similar result in CDN$.

I get a 10-year median Price/Cash Flow per Share Ratio of 12.03. The current ratio is 14.05 based on Cash Flow per Share estimate for 2025 of $12.49, Cash Flow of $6,302M and a stock price of $175.44. The current ratio is 17% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median. This testing is in US$ and you will get a similar result in CDN$.

I get an historical median dividend yield of 1.03%. The current dividend yield is 0.91% based on dividends of $1.60 and a Stock Price of $175.44. The current dividend yield is 11% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively reasonable but above the median. This testing is in US$ and you will get a similar result in CDN$.

I get a 10 year median dividend yield of 1.03%. The current dividend yield is 0.91% based on dividends of $1.60 and a Stock Price of $175.44. The current dividend yield is 32% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively expensive. This testing is in US$ and you will get a similar result in CDN$.

The 10-year median Price/Sales (Revenue) Ratio is 4.24. The current P/S Ratio is 7.54 based on a stock price of $175.44, Revenue estimate for 2025 of $11,741M and Revenue per Share of $23.27. The current ratio is 78% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. This testing is in US$ and you will get a similar result in CDN$.

Results of stock price testing is that the stock price is probably expensive. The 10 year dividend yield test is saying that the stock price is relatively expensive and this is confirmed by the P/S Ratio test. The rest of the testing runs from cheap to expensive. Note that this company publishes it financials in US$ and the estimates are given in US$.

When I look at analysts’ recommendations, I find Strong Buy (11), Buy (5), Hold (3), and Sell (1). The consensus is a Strong Buy. The 12 month stock price consensus is $271.36 ($197.08 US$) with a high of $351.11 ($255.00 US$) and low of $96.38 ($70.00 US$). The consensus stock price of $271.36 implies a total return of 13.15% with 12.23% from capital gains and 0.91% from dividends based on a current stock price of $241.78.

Analysts on Stock Chase certainly like this company. Many say be cautious as gold producers could be overbought. Chris MacDonald on Motley Fool likes gold as a hedge against uncertainty. Amy Legate-Wolfe on Motley Fool likes this stock as a low-risk way to ride the gold rally. I am not sure I agree with this as gold has always been rather cyclical. The company put out a Press Release about their fourth quarter of 2024. The company put out a Press Release about their third quarter of 2025.

Zacks via Yahoo Financial reviews this stock and really likes it. Simply Wall Street via Yahoo Finance reviews this stock. They think it is overvalued by 99% with a fair value of $72.37 US$. They have one warning of significant insider selling over the past 3 months.

Agnico Eagle is a gold miner with mines in Canada, Mexico, Finland, and Australia. Its web site is here Agnico Eagle Mines Ltd.

The last stock I wrote about was about was KP Tissue Inc (TSX-KPT, OTC-KPTSF) ... learn more. The next stock I will write about will be Titanium Transportation Group Inc (TSX-TTNM, OTCQX-TTNMF) ... learn more on Monday, December 22, 2025 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Wednesday, December 17, 2025

KP Tissue Inc

Sound bite for Twitter is: Dividend Paying Consumer. Results of stock price testing is that the stock price is probably reasonable. The company of KP Tissue has no debt, but their Liquidity Ratio is too low. The Dividend Payout Ratios (DPR) are far too high. The current dividend yield is good with dividend growth nil. See my spreadsheet on KP Tissue Inc.

Is it a good company at a reasonable price? This is not a dividend growth stock. It seems that they cannot afford to pay a dividend. I like companies that grow their dividends over time and produce a total return in the long term of at least 8% per year. This stock does not fit. They are not growing their dividends. Shareholders have not done well with stock over the past 12 years. See Total Return per Year section below. The current stock price seems reasonable.

I do not own this stock of KP Tissue Inc (TSX-KPT, OTC-KPTSF). This was a stock suggested by a speaker at the Ellen's Investment Club. It is not a dividend growth stock.

When I was updating my spreadsheet, I find this analysis complicated. How well Kruger is doing is more important that what KP Tissue is doing as KP Tissue just owns shares in Kruger. I cannot probably analyze Kruger as I do not know what the company is worth. You really need to analyze two companies. And, I do not want to spend more time on a stock that I know I would never buy.

If you had invested in this company in December 2014, for $1,000.64 you would have bought 51 shares at $16.96 per share. In December 2024, after 10 years you would have received $424.80 in dividends. The stock would be worth $4.85.57. Your total return would have been $910.37. This would be a total loss of 1.18% per year with 6.08% from capital loss and 5.79% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$16.96 $1,000.64 59 10 $424.80 $485.57 $910.37

The current dividend yield is good with dividend growth nil. The dividend yield is good (5% to 6% ranges) at 6.91%. The 5, 10 year and historical median dividend yields are all good at 6.72%, 6.61% and 6.44%. The dividends are not increasing and have never increased. Although the first dividend payment in 2013 was almost 5% higher than other dividends paid.

The Dividend Payout Ratios (DPR) are far too high. The DPR for 2024 for Earnings per Share (EPS) is far too high at 300% with 5 year coverage non-calculable because of earnings losses apparently transfer from Kruger. The DPR for 2024 for Cash Flow per Share (CFPS) is non-calculable because of no Cash Flow. The DPR for 2024 for Free Cash Flow (FCF) is too high at 100% with 5 year coverage at 100%. FCF varied from $0.6M to 26.66. I am using 6.974M.

Item Cur 5 Years
EPS 300.00% 0.00%
CFPS 0.00% 0.00%
FCF 100.14% 100.03%

The company of KP Tissue has no debt, but their Liquidity Ratio is too low. The Long Term Debt/Market Cap Ratio for 2024 is good at 0.00 and currently at 0.00 because the company has no long term debt. The Liquidity Ratio for 2024 is too low at 1.00 and 1.00 currently. If you added in Cash Flow after dividends, the ratios are even lower as there is no Cash Flow at 0.20 and currently at 0.20. The Debt Ratio for 2024 is good at 39.66 and 39.59 currently because KP Tissue has no debt. The Leverage and Debt/Equity Ratios for 2024 are good at 1.03 and 0.03 and currently at 1.03 and 0.03.

Type Year End Ratio Curr
Lg Term R 0.00 0.00
Intang/GW 0.00 0.00
Liquidity 1.00 1.00
Liq. + CF 0.20 0.20
Debt Ratio 39.66 39.59
Leverage 1.03 1.03
D/E Ratio 0.03 0.03

The Total Return per year is shown below for years of 5 to 12 to the end of 2024. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2019 5 0.00% 4.79% -3.13% 7.92%
2014 10 0.00% -1.18% -6.98% 5.79%
2012 12 -0.36% -6.08% 5.72%

The 5 and 10 year low, median, and high median Price/Earnings per Share Ratios are negative, so I cannot do any P/E Testing. The current P/E Ratio is 11.58 based on a stock price of $10.42 and EPS estimate for 2025 of $0.90. This is a reasonable P/E Ratio, so the stock price would probably be reasonable.

I get a Graham Price of $10.42. The 10-year low, median, and high median Price/Graham Price Ratios are 2.91, 4.36 and 5.82. The current P/GP Ratio is 0.88 based on a stock price of $10.42. The current ratio is below the low ratio of the 10 year median ratio. These 10 year median ratios are really high because a reasonable ratio would be from around 0.80 to 1.20. The current ratio would be considered a low ratio and so the stock price would be reasonable.

I get a 10-year median Price/Book Value per Share Ratio of 1.31. The current ratio is 1.50 based on a Book Value of $69.5M, Book Value per Share of $6.96 and a stock price of $10.42. The current ratio is 14% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I also have a Book Value per Share estimate for 2025 of $8.35. This implies a book value of $8.3M and a ratio of 1.25. This ratio is 5% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I cannot do any Price/Cash Flow per Share Ratio test because the stock has no Cash Flow.

I get an historical median dividend yield of 6.44%. The current dividend yield is 6.91% based on dividends of $0.72 and stock price of $10.42. The current dividend yield is 7.3% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a 10 year median dividend yield of 6.61%. The current dividend yield is 6.91% based on dividends of $0.72 and stock price of $10.42. The current dividend yield is 4.5% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively reasonable and below the median.

The 10-year median Price/Sales (Revenue) Ratio is 0.48. The current ratio is 0.37 based on Kruger Revenue estimate for 2025 of $2,211M, Revenue per Share of $28.08 and a Stock Price for KPT of $10.42. The current ratio is 23% below the 10 year median ratio. This stock price testing suggests that the stock price is cheap.

Results of stock price testing is that the stock price is probably reasonable. The dividend yield testing is showing this. However, these are not particularly good tests when dividends do not increase. The P/S Ratio testing seems to show that the stock is relatively cheap. The rest of the testing is probably showing that the stock price is reasonable, but some of the tests are no clean. For example, I cannot do a P/E Ratio test because of earnings losses.

When I look at analysts’ recommendations, I find only a Hold (4). The 12 month consensus stock price is $10.50 with a high a $11.00 and low of $10.00. The consensus stock price of $10.52 implies a total return of 7.68%, with 0.77% from capital gains and 6.91% from dividends based on a stock price of $10.42.

There a few entries on Stock Chase for this company. The last one was in 2023 and it was a Do Not Buy. He said we are not very impressed by the fundamentals or financials. Amy Legate-Wolfe on Motley Fool she says the opportunity today comes from the fact that KPT still trades under the radar and often at a valuation that doesn’t reflect its long-term stability. Aditya RaghunathMotley Fool likes it because of the high dividend yield. The company put out a press release via Globe Newswire about their fourth quarter of 2024 results. The company put out a press release via Globe Newswire about their third quarter for 2025.

GuruFocus News via Yahoo Finance recently wrote on this stock. They gave both the positive and negative points to the company. They said they have 3 warnings out on this stock but do not say what they are. Simply Wall Street has no write up on this stock but they have two warnings of makes less than USD$1m in revenue (CA$0) and does not have a meaningful market cap (CA$105M).

KP Tissue Inc is a holding company. Through its equity holdings in Kruger Products Inc. (the operating company), it is involved in the business of producing, distributing, marketing, and selling various disposable tissue products, including bathroom tissue, facial tissue, paper towels, and napkins for both the consumer and away-from-home markets in North America. Geographically, the company derives maximum revenue from Canada and the rest from the United States. Its web site is here KP Tissue Inc.

The last stock I wrote about was about was Maple Leaf Foods Inc (TSX-MFI, OTC-MLFNF) ... learn more. The next stock I will write about will be Agnico Eagle Mines Ltd (TSX-AEM, NYSE-AEM) ... learn more on Friday, December 19, 2025 around 5 pm. Tomorrow on my other blog I will write about Small-Cap Stocks .... learn more on Thursday, December 18, 2025 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Monday, December 15, 2025

Maple Leaf Foods Inc

Sound bite for Twitter is: Dividend Paying Consumer. Results of stock price testing is that the stock price is probably reasonable. Debt Ratios are fine. The Dividend Payout Ratios (DPR) need improving and analysts believe it will be. The current dividend yield is moderate with a recent dividend cut. See my spreadsheet on Maple Leaf Foods Inc.

Is it a good company at a reasonable price? When dividends are cut, it is never a good sign. It seems to reflect a negative view of the future by the company. So, I believe caution on buying this stock is warranted.

I do not own this stock of Maple Leaf Foods Inc (TSX-MFI, OTC-MLFNF). I am doing a report on this stock because it was on the Top 100 Canadian Dividend Stocks by Maple Money . Note that this list does not seem to have changed since 2022. It also was on the Top 100 Dividend Stocks Money Sense for 2021 gets a solid C Rating from Money Sense. For the Money Sense list, this stock in 2025 gets an E rating

When I was updating my spreadsheet, I noticed this company has decreased their dividends by 21% for December 2025 Dividend Payment. The last time the dividends were decreased was in 1995. I have 34 years of dividend data. Dividend have been increased in 10 years and decreased in 2 years. See the press release from Maple Leaf Foods Inc on this.

If you had invested in this company in December 2014, for $1,012.44 you would have bought 52 shares at $19.47 per share. In December 2024, after 10 years you would have received $317.20 in dividends. The stock would be worth $939.64. Your total return would have been $1,256.84. This would be a total return of 2.42% per year with 0.74% from capital loss and 3.17% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$19.47 $1,012.44 52 10 $317.20 $939.64 $1,256.84

The current dividend yield is moderate with a recent dividend cut. The current dividend is moderate (2% to 4% ranges) at 3.00%. The 5 and 10 year median dividend yields are moderate at 3.07% and 2.27%. The historical median dividend yield is low (below 2%) at 1.49%. Dividends have been increasing since 2015, but this year the company cut the dividends by 21%. This is the last dividend change and it is for the December 2025 dividend payment.

The Dividend Payout Ratios (DPR) need improving and analysts believe it will be. The DPR for 2024 for Earnings per Share (EPS) is far too high at 113% with 5 year coverage 5 year coverage non-calculable due to earning losses. The DPR for 2024 for Adjusted Earnings per Share (AEPS) is far too high at 113% with 5 year coverage at 236%. The DPR for 2024 for Cash Flow per Share (CFPS) is good at 28% with 5 year coverage too high at 64%. The DPR for 2024 for Free Cash Flow (FCF) is good at 25% with 5 year coverage at 31%. FCF for 2024 varies from $368.3M to $460M. I am using the $460M value.

Item Cur 5 Years
EPS 112.82% 0.00%
AEPS 112.82% 235.64%
CFPS 27.33% 64.42%
FCF 25.13% 30.76%

Debt Ratios are fine. The Long Term Debt/Market Cap Ratio for 2024 is fine at 0.62 and currently good at 0.47. The Liquidity Ratio for 2024 is low at 1.23 and 1.26 currently. If you added in Cash Flow after dividends, the ratios are fine at 1.54 and currently at 1.47. The Debt Ratio for 2024 is good at 1.53 and 1.51 currently. The Leverage and Debt/Equity Ratios for 2024 are fine at 2.88 and 1.88 and currently at 2.95 and 1.95.

Type Year End Ratio Curr
Lg Term R 0.62 0.47
Intang/GW 0.15 0.11
Liquidity 1.23 1.26
Liq. + CF 1.54 1.47
Debt Ratio 1.53 1.51
Leverage 2.88 2.95
D/E Ratio 1.88 1.95

The Total Return per year is shown below for years of 5 to 34 to the end of 2024. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2018 5 8.70% -3.45% -6.93% 3.48%
2013 10 18.59% 2.42% -0.74% 3.17%
2008 15 12.04% 5.81% 2.96% 2.85%
2003 20 8.90% 3.07% 0.95% 2.12%
1998 25 7.06% 2.93% 1.03% 1.90%
1993 30 2.84% 3.14% 1.30% 1.84%
1990 34 2.50% 3.62% 1.50% 2.11%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 18.58, 26.79, 33.65. The corresponding 10 year ratios are 21.07, 27.42 and 34.33. The corresponding historical ratios are 16.76, 19.72 and 24.60. The current ratio is 23.64 based on Stock Price of $25.30, EPS estimate for 2025 of $1.07. The current ratio is between the low and median ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are 19.82, 26.79 and 30.74. The corresponding 10 year ratios are 20.76, 26.10 and 30.23. The corresponding historical ratios are 20.55, 25.09 and 29.41. The current ratio is 24.56 based on Stock Price of $25.30, AEPS estimate for 2025 of $1.03. The current ratio is between the low and median ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a Graham Price of $16.82. The 10-year low, median, and high median Price/Graham Price Ratios are 1.16, 1.44, 1.69. The current P/GP Ratio is 1.50 based on a stock price of $25.30. The current ratio is between the median and high ratios of the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I get a 10-year median Price/Book Value per Share Ratio of 1.74. The current ratio is 2.07 based on Book Value of $1,510M, Book Value per Share of $12.20 and a stock price of $25.30. The current ratio is 19% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I also have Book Value per Share estimate for 2025 of $11.83. This implies a Book Value of $1,464M and a ratio of 2.14 based on a stock price of $25.30. This ratio is 23% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I get a 10-year median Price/Cash Flow per Share Ratio of 12.01. The current ratio is 8.66 based on Cash Flow per Share estimate for 2025 of $2.92, Cash Flow of $361.4M and a stock price of $25.30. The current ratio is 28% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get an historical median dividend yield of 1.49%. The current dividend is 3% based on Dividends of $0.76 and a stock price of $25.30. The current dividend yield is 102% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.

I get a 10 year median dividend yield of 2.27%. The current dividend is 3% based on Dividends of $0.76 and a stock price of $25.30. The current dividend yield is 32% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.

The 10-year median Price/Sales (Revenue) Ratio is 0.82. The current is 0.80 based on Revenue estimate for 2025 of $3,927M. Revenue per Share of $31.73 and a stock price of $25.30. The current ratio is 3% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

Results of stock price testing is that the stock price is probably reasonable. The dividend yield testing says that the stock price is relatively cheap. The P/S Ratio test does not confirm this but says the stock price is relatively reasonable and below the median. The rest of the testing goes from cheap to expensive.

When I look at analysts’ recommendations, I find Strong Buy (4), Buy (3), and Hold (2). The consensus is a Strong Buy. The 12 month stock price consensus is $33.88 with a high of $42.00 and low of $27.00. The consensus stock price of $33.88 implies a total return of 36.92% with 33.91% from capital gains and 3.00% from dividends based on a current stock price of $25.30.

Last year when I look at analysts’ recommendations, I found Strong Buy (3), and Buy (2). The consensus would be a Strong Buy. The 12 month stock price consensus is $29.80 with a high of $34.00 and low of 26.00. The 12 month consensus price implies a total return of 40.22% with 36.20% from capital gains and 4.02% from dividends based on a stock price of $21.88. What happened was an increase in stock price of $21.88 to $25.30, a 15.63% increase for a total return of 19.65% with 4.02% from dividends.

Analysts on Stock Chase mainly to say to watch the stock as it may improve. One says it is too volatile for a consumer staples company. I must say that I do agree with that assessment. Christopher Liew on Motley Fool says that Buy Canada movement help the company and made it into a stock for long term investors. Chris MacDonald on Motley Fool thinks this stock is a passive income gem. The company put out a Press Release about their year-end results for 2024. The company put out a Press Release about their third quarter of 2025 results.

Simply Wall Street via Yahoo Finance reviews this stock. They think it is undervalued. They also say that Maple Leaf Foods (TSX-MFI) just signed on as the Official Protein Partner of Team Canada for the 2026 and 2028 Olympics, a branding move that has quickly focused investor attention on the stock.

Maple Leaf Foods Inc is a protein company that responsibly produces food products under brands including Maple Leaf, Maple Leaf Prime, Maple Leaf Natural Selections, Schneiders, Mina, Greenfield Natural Meat Co., Lightlife and Field Roast. The Company's portfolio includes prepared meats, ready-to-cook and ready-to-serve meals, and valued-added fresh pork and poultry, and plant protein products. Its main markets are Canada, the United States, Japan, and China. Its web site is here Maple Leaf Foods Inc.

The last stock I wrote about was about was Element Fleet Management Corp (TSX-EFN, OTC-ELEEF) ... learn more. The next stock I will write about will be KP Tissue Inc (TSX-KPT, OTC-KPTSF) ... learn more on Wednesday, December 17, 2025 around 5 pm. Tomorrow on my other blog I will write about Canadian Banks Fourth Quarters.... learn more on Tuesday, December 16, 2025 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Friday, December 12, 2025

Element Fleet Management Corp

Sound bite for Twitter is: Dividend Growth Financial. Results of stock price testing is that the stock price is probably expensive. Debt Ratios are fine. The Dividend Payout Ratios (DPR) are good. The current dividend yield is low with dividend growth good. See my spreadsheet on Element Fleet Management Corp.

Is it a good company at a reasonable price? It would seem that dividend growth has really slowed down as the last increase was for 8.3% whereas the 5 year dividend growth per year is 21.6%. Note that Cash Flow without Working Capital has positive growth, unlike just Cash Flow. If you like to company, but careful as it is testing expensive. It is always wise to make several purchases over time rather than just one purchase. The stock is testing as expensive and check on the 10 year dividend yield test, the stock would have to be around $25.75 at a minimum to pass this test.

I do not own this stock of Element Fleet Management Corp (TSX-EFN, OTC-ELEEF). I was looking for stocks to follow and I found this stock in 100 best Dividend Stocks Money Sense for 2018. It was also on Raymond James' top 19 Canadian stocks for 2019 list.

When I was updating my spreadsheet, I noticed the company has switched their accounting from CDN$ to US$ starting this year. However, analysts who give out estimates are still giving estimates in CDN$. Of the officers and directors, I am following the CEO has increased his shares in the company, but one officer and one director have decreased their shares in the company.

If you had invested in this company in December 2014, for $1,002.14 you would have bought 89 shares at $11.26 per share. In December 2024, after 10 years you would have received $551.34 in dividends. The stock would be worth $2,586.34. Your total return would have been $3,137.68. This would be a total return of 14.67% per year with 9.95% from capital gain and 4.73% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$11.26 $1,002.14 89 10 $551.34 $2,586.34 $3,137.68

In the chart below, I am showing 5 and 10 year total growth and per year growth in columns 3 and 4. In column 5, I am showing what growth has been over the past 12 months and what is expected to the end of this year. You can see from this chart that they are growing every item except Cash Flow. However, Cash Flow excluding Working Capital is growing.

Yr Item Tot. Gwth Per Year Gwth Coverage
5 Revenue Growth US$ 42.09% 7.28% 2.46% <-12 mths
5 AEPS Growth 72.13% 11.47% 6.36% <-12 mths
5 Net Income Growth 470.16% 41.64% 11.56% <-12 mths
5 Cash Flow Growth -113.40% N/C -190.08% <-12 mths
5 Dividend Growth 140.16% 19.21% 12.47% <-12 mths
5 Stock Price Growth 139.88% 19.12% 29.40% <-12 mths
10 Revenue Growth US$ 277.82% 14.22% 10.39% <-this year
10 AEPS Growth 750.74% 23.87% 13.64% <-this year
10 Net Income Growth 930.26% 26.27% 15.61% <-this year
10 Cash Flow Growth -149.52% N/C 696.77% <-this year
8 Dividend Growth 347.91% 23.89% 33.85% <-this year
10 Stock Price Growth 104.97% 7.44% 29.40% <-this year
5 Revenue Growth CDN$ 57.42% 9.50% 2.46% <-12 mths
5 AEPS Growth 90.70% 13.78% 2.45% <-12 mths
5 Net Income Growth 470.16% 41.64% 11.56% <-12 mths
5 Cash Flow Growth -114.84% N/C -190.08% <-12 mths
5 Dividend Growth 166.67% 21.67% 8.33% <-12 mths
5 Stock Price Growth 162.04% 21.25% 25.46% <-12 mths
10 Revenue Growth CDN$ 368.61% 16.70% 6.33% <-this year
10 AEPS Growth 955.19% 26.57% 9.46% <-this year
10 Net Income Growth 930.26% 26.27% 15.61% <-this year
10 Cash Flow Growth -161.42% N/C 674.83% <-this year
8 Dividend Growth 380% 25.12% 33.85% <-this year
10 Stock Price Growth 158.08% 9.95% 25.46% <-this year

The current dividend yield is low with dividend growth good. The current dividend yield is low (below 2%) at 1.44%. The 5, 8 year and historical median dividend yields are moderate (2% to 4% ranges) at 2.02% for all periods. The dividend growth is good (above 15% per year) at 23.6% per year over the past 5 years. The last dividend increase was in 2025 and it was for 8.3%.

The Dividend Payout Ratios (DPR) are good. The DPR for 2024 for Earnings per Share (EPS) is good at 38% with 5 year coverage at 37%. The DPR for 2024 for Adjusted Earnings per Share (AEPS) is good at 33% with 5 year coverage at 30%. The DPR for 2024 for Cash Flow per Share (CFPS) is good at 14% with 5 year coverage at 10%. The DPR for 2024 for Free Cash Flow (FCF) is too high at 78% with 5 year coverage good at 35%. FCF for 2024 varies from a negative $662M to a positive $803M. I am using $188M.

Item Cur 5 Years
EPS 38.04% 37.02%
AEPS 32.85% 30.43%
CFPS 13.94% 9.63%
FCF 78.07% 35.13%

Debt Ratios are fine. The Long Term Debt/Market Cap Ratio for 2024 is too high at 1.03 and currently high at 0.81. However, we need also to look at the Long Term Debt/Covering Assets Ratio for 2024 which is too high at 1.04 and currently fine at 0.91 because this is a more important ratio for a Financials. The Liquidity Ratio for 2024 is low at 0.46 and 0.50 currently, but this ratio is not important for financials. The Debt Ratio for 2024 is fine at 1.28 and 1.25 currently. The Leverage and Debt/Equity Ratios for 2024 are fine for financials at 4.58 and 3.58 and currently at 4.98 and 3.98.

Type Year End Ratio Curr
Lg Term R 1.03 0.81
Lg Term R+A 1.04 0.91
Intang/GW 0.20 0.16
Liquidity 0.46 0.50
Liq. + CF 0.40 0.79
Debt Ratio 1.28 1.25
Leverage 4.58 4.98
D/E Ratio 3.58 3.98

The Total Return per year is shown below for years of 5 to 13 to the end of 2024 in CDN$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2019 5 21.67% 23.14% 21.25% 1.89%
2014 10 21.66% 14.67% 9.95% 4.73%
2011 13 19.68% 14.86% 4.83%

The Total Return per year is shown below for years of 5 to 13 to the end of 2024 in US$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2019 5 19.21% 21.06% 19.12% 1.94%
2014 10 20.61% 11.63% 7.44% 4.19%
2011 13 16.03% 11.86% 4.17%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 15.40, 17.88 and 20.79. The corresponding 10 year ratios are 15.49, 18.34 and 21.44. The corresponding historical ratios are 14.26, 17.78 and 20.41. The current ratio is 22.41 based on a stock price of $36.06 and EPS estimate for 2025 of $1.61. The current ratio is above the high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive. This testing is in CDN$.

I also have Adjusted Earning per Share (AEPS) data. The 5-year low, median, and high median Price/Earnings per Share Ratios are 12.88, 14.94 and 18.38. The corresponding 10 year ratios are 10.18, 12.81 and 16.10. The corresponding historical ratios are 9.46, 12.29 and 15.70. The current ratio is 20.98 based on a stock price of $26.23 and AEPS estimate for 2025 of $1.25. The current ratio is above the high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive. This testing is in US$ and you would get a similar result in CDN$.

I get a Graham Price of $19.53. The 10-year low, median, and high median Price/Graham Price Ratios are 0.65, 0.83 and 1.07. The current ratio is 1.85 based on a stock price of $36.06. The current ratio is above the high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive. This testing is in CDN$.

I get a 10-year median Price/Book Value per Share Ratio of 1.19. The current P/B Ratio is 3.68 based on a Book Value of $3,920.4M, Book Value per Share of $9.79 and a stock price of $36.06. The current ratio is 211% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. This testing is in CDN$.

I get a 10-year median Price/Cash Flow per Share Ratio of 2.27. The current P/CF Ratio is 16.29 based on a Stock Price of $36.06, Cash Flow per Share estimate for 2025 of $2.21 and Cash Flow of $886.3M. The current ratio is 617% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. This testing is in CDN$.

I get an historical median dividend yield of 1.94%. The current dividend yield is 1.44% based on a stock price of $36.06 and dividends of $0.52. The current dividend yield is 26% below the historical median dividend. This stock price testing suggests that the stock price is relatively expensive. This testing is in CDN$.

I get a 10 year median dividend yield of 1.94%. The current dividend yield is 1.44% based on a stock price of $36.06 and dividends of $0.52. The current dividend yield is 26% below the 19 year median dividend. This stock price testing suggests that the stock price is relatively expensive. This testing is in CDN$.

The 10-year median Price/Sales (Revenue) Ratio is 5.06. The current P/S Ratio is 8.68 based on a stock price of $36.06, Revenue estimate for 2025 of $1,664M and Revenue per Share of $4.50. The current ratio is 71% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. This testing is in CDN$.

Results of stock price testing is that the stock price is probably expensive. The dividend yield testing is saying that the stock price is relatively expensive. It is confirmed by the P/S Ratio test. All the other tests are saying the same thing. The stock price would have to be at $26.75 or lower to pass the 10 year median dividend yield test.

When I look at analysts’ recommendations, I find Strong Buy (5), Buy (3) and Hold (2). The consensus would be a Strong Buy. The 12 month stock price consensus is $42.30 with a high of $48.00 and low of $39.00. The consensus stock price of $42.30 implies a total return of 18.75% with 17.30% from capital gains and 1.44% from dividends based on a current stock price of $36.06.

Most analysts on Stock Chase really like this stock. However, one says sell because it is highly leveraged. Tony Dong on Motley Fool reviews this stock and thinks it is a good buy as it is a compounder. Christopher Liew on Motley Fool thinks that this stock will continue to rise. The company put out a Press Release about their third quarter of 2025. The company put out a Press Release about their fourth quarter of 2024.

Simply Wall Street via Yahoo Finance reviews this stock and its dividend payments. They have one warning out on this stock of Interest payments are not well covered by earnings.

Element Fleet Management Corp is a fleet management company, providing services and financings for commercial vehicle and equipment fleets. The company operates in the U.S., Canada, Mexico, Australia, and New Zealand. Key revenue is generated from United States and Canada. Its web site is here Element Fleet Management Corp.

The last stock I wrote about was about was Bird Construction Inc (TSX-BDT, OTC-BIRDF) ... learn more. The next stock I will write about will be Maple Leaf Foods Inc (TSX-MFI, OTC-MLFNF) ... learn more on Monday, December 15, 2025 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Wednesday, December 10, 2025

Bird Construction Inc

Sound bite for Twitter is: Dividend Growth Industrial. Results of stock price testing is that the stock price is showing that the stock price is relatively expensive. Debt Ratios have problems and there is too much debt. The Dividend Payout Ratios (DPR) are good. The current dividend yield is moderate with dividend growth currently low. See my spreadsheet on Bird Construction Inc.

Is it a good company at a reasonable price? The stock price has recently gone up a lot. The company has too much debt. They now seem to have set the dividends at a good level of payment. I do not like the Liquidity Ratio as it is too low. I know that analysts’ recommendation is a Strong Buy, but they put that on most stocks. This stock is testing as being in the expensive range.

I do not own this stock of Bird Construction Inc (TSX-BDT, OTC-BIRDF). This was listed as a top stock in ETF of iShares S&P TSX Canadian Dividend Aristocrats Index. I had not heard of it before, so I decided to do a spreadsheet on this stock in 2016.

When I was updating my spreadsheet, I noticed that over the past 5 years, this stock’s capital gain was 29.5% per year. The stock increased in price in 2023 by 77% and in 2024 by 81%. The stock is only up 9.63% this year so far. All the officers and one director I am following bought shares in the past year. The latest purchase was for $25.31. This company has a lot of debt. The Leverage and Debt/Equity Ratios are 4.20 and 3.20. You want these ratios to be below 3.00 and 2.00. Dividends are inconsistent. In the last 24 years, dividends were up in 13 years and down in 4 years.

The current dividend yield is moderate with dividend growth currently low. The current dividend yield is moderate (2% to 4% ranges) at 2.94%. The 5year median dividend yield is moderate at 4.23%. The 10 year and historical median dividend yields are good (5% to 6% ranges) at 5.03% and 5.70%. The dividend growth over the past 5 years is low (below 8%) at 7.16%. The last dividend increase was for 50% and it was in 2024. Note that dividends were cut in 2017. Dividends for 2025 are now 10% above dividends in 2016.

The Dividend Payout Ratios (DPR) are good. The DPR for 2024 for Earnings per Share (EPS) is good at 30% with 5 year coverage at 38%. The DPR for 2024 for Adjusted Earnings per Share (AEPS) is good at 27% with 5 year coverage at 37%. The DPR for 2024 for Cash Flow per Share (CFPS) is good at 13% with 5 year coverage at 23%. The DPR for 2024 for Free Cash Flow (FCF) is good at 19% with 5 year coverage at 25%. FCF varies in 2024 from $96.21M to $160M. I am using the $96.21M value.

Item Cur 5 Years
EPS 29.95% 37.56%
AEPS 27.01% 37.16%
CFPS 13.35% 22.57%
FCF 18.75% 25.42%

Debt Ratios have problems and there is too much debt. The Long Term Debt/Market Cap Ratio for 2024 is good at 0.09 and currently at 0.08. The Liquidity Ratio for 2024 is low at 1.27 and 1.28 currently. If you added in Cash Flow after dividends, the ratios are low at 1.35 and currently at 1.37. The Debt Ratio for 2024 is low at 1.31 and 1.33 currently. The Leverage and Debt/Equity Ratios for 2024 are far too high at 4.20 and 3.20 and currently at 4.06 and 3.06. I like to see these ratios below 3.00 and 2.00.

Type Year End Ratio Curr
Lg Term R 0.09 0.08
Intang/GW 0.16 0.15
Liquidity 1.27 1.28
Liq. + CF 1.35 1.37
Debt Ratio 1.31 1.33
Leverage 4.20 4.06
D/E Ratio 3.20 3.06

The Total Return per year is shown below for years of 5 to 27 to the end of 2024. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2019 5 7.16% 33.23% 29.52% 3.71%
2014 10 -3.16% 11.29% 8.13% 3.16%
2009 15 0.11% 9.40% 5.63% 3.77%
2004 20 2.70% 29.76% 12.82% 16.94%
1999 25 7.21% 36.44% 15.63% 20.80%
1997 27 49.59% 20.23% 29.36%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 6.23, 8.53 and 11.03. The corresponding 10 year ratios are 8.58, 12.02 and 15.46. The corresponding historical ratios are 6.91, 9.98 and 11.30. The current ratio is 18.09 based on a stock price of $28.57 and EPS estimate for 2025 of 1.58. The current ratio is above the high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Earnings per Share Ratios are 6.64, 9.07 and 11.02. The corresponding 10 year ratios are 7.45, 10.45 and 13.11. The corresponding historical ratios are 8.12, 10.03 and 11.41. The current ratio is 15.04 based on a stock price of $28.57 and AEPS estimate for 2025 of 1.90. The current ratio is above the high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive. The current ratio is above the high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive.

I get a Graham Price of $18.79. The 10-year low, median, and high median Price/Graham Price Ratios are 0.89, 1.24 and 1.63. The current P/GP Ratio is 1.52 based on a stock price of $28.57. The current ratio is between the median and high ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I get a 10-year median Price/Book Value per Share Ratio of 2.30. The current P/B Ratio is 3.46 based on a stock price of $28.57, Book Value of $457.4M and Book Value per Share of $8.26. The current ratio is 51% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I get a 10-year median Price/Cash Flow per Share Ratio of 7.42. The current P/CF Ratio is 11.41 based on Cash Flow per Share estimate for 2025 of $2.50, Cash Flow of $138.7M and a stock price of $28.57. The current ratio is 54% above the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive.

I get an historical median dividend yield of 5.70%. The current dividend yield is 2.94% based on a stock price of $28.57 and dividends of $0.84. The current ratio is 48% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively expensive.

I get a 10 year median dividend yield of 5.03%. The current dividend yield is 2.94% based on a stock price of $28.57 and dividends of $0.84. The current ratio is 42% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively expensive. The reason for quite high past dividend yields is that this stock used to be an Income Trust. Income Trust could pay much higher dividends than corporations could and so had high dividend yields. However, this company changed to a corporation in 2011, more than 10 years ago. On the other hand, old Income Trusts have had a hard time setting dividends at the right level.

The 10-year median Price/Sales (Revenue) Ratio is 0.23. The current P/S Ratio is 0.46. Based on a stock price of $28.57, Revenue estimate for 2025 of $3,429M and Revenue per Share of $61.91. The current ratio is 101% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

Results of stock price testing is that the stock price is showing that the stock price is relatively expensive. The dividend yield tests are showing this. It is confirmed by the P/S Ratio test. The rest of the testing I have done says the same thing.

When I look at analysts’ recommendations, I find Strong Buy (5), and Buy (3). The consensus is a Strong Buy. The 12 month stock price is $33.62 with a high of $36.00 and low of $31.00. The consensus stock price of $33.62 implies a total return of 20.62% with 17.68% from capital gains and 2.94% from dividends based on a current stock price of $28.57.

A couple of analysts on Stock Chase point to this company’s small size. One analyst says that the company needs a bit more consistency in execution and meeting estimates. Sneha Nahata on Motley Fool says the stock is under $30 and a screaming buy. She says it is a solid long term buy. Amy Legate-Wolfe on Motley Fool says the company is Under-the-radar Canadian industrials that could reward patient investors. The company put out a Press Release about its fourth quarter 2024 results. The company put out a Press Release about its fourth quarter of 2025.

Simply Wall Street via Yahoo Finance reviews this stock. They do not like their inconsistency in dividends. They have one warning of Dividend of 3.05% is not well covered by free cash flows.

Bird Construction Inc. is a construction company operating from coast to coast and servicing all Canada's markets. It also provides vertical infrastructure, including electrical, mechanical, and specialty trades. Its web site is here Bird Construction Inc.

The last stock I wrote about was about was Sienna Senior Living Inc (TSX-SIA, OTC-LWSCF) ... learn more. The next stock I will write about will be Element Fleet Management Corp (TSX-EFN, OTC-ELEEF) ... learn more on Friday, December 12, 2025 around 5 pm. Tomorrow on my other blog I will write about Secure Waste Infrastructure Corp.... learn more on Thursday, December 11, 2025 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures. Also, on my book blog I have put a review of the book On Democracies and Death Cults by Douglas Murray learn more...